FTC warns PBM practices are driving higher drug costs and employers start to push back
This year, a combination of rising pharmacy costs and increased regulatory risk has led to a tipping point for the PBM industry.
US-Rx Care
This year, a combination of rising pharmacy costs and increased regulatory risk has led to a tipping point for the PBM industry.